Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My guess is that Nader's cash was "loaned" to someone else who now invests for Nader in the dips and sells at the peaks. Obviously, Nader directs the trading with his insider info. This is another reason we know trial results are poor: the stock price would have risen over the last week instead of decay if trial results were good.
It is weird how the stock price is stuck on $4.60 right now. My guess is that Nader put in a limit buy order at $4.60 before the Proactive video aired to temporarily prevent it from sinking. It probably used to hurt his pride how the stock price would always sink as soon as he would start speaking on the conference calls that happened during trading hours.
Nader wasn't excited at all. That isn't a good sign. And at the end, notice how his eyes quickly shift left before he says they can't wait to put out their CD12 data. Hahahaha. This stock will soon be $1 just like before Covid happened.
We have no idea if Dr Reddy is stealing or was given permission. Even if he is stealing, imitation is the sincerest form of flattery. In other words, he wouldn't be stealing if he wasn't confident that RLF-100 had potential because trials are expensive. And who really cares about India? All of the poorest countries have black market pharmaceutical drugs.
Dr Reddy's, Zuventus get nod to conduct Covid-19 trials on repurposed drugs
https://www.business-standard.com/article/companies/dr-reddy-s-zuventus-get-nod-to-conduct-covid-19-trials-on-repurposed-drugs-121012501695_1.html
The subject expert committee (SEC) has given the go-ahead to a clutch of firms, including Dr Reddy’s Laboratories (DRL) and Zuventus Healthcare, to conduct clinical trials on repurposed drugs for Covid-19.
Mumbai’s Zuventus and Hyderabad’s DRL have got the nod to conduct Phase 3 clinical trials of Aviptadil injectable formulation. Aviptadil — a vasoactive intestinal polypetide used to treat erectile dysfunction — has been found to be useful in treating respiratory distress in Covid-19 patients. The US Food and Drug Administration has allowed emergency-use of the drug for treating Covid-19 patients.
NeuroRx and Relief Therapeutics have partnered to develop a drug called RLF-100 that has anti-inflammatory and anti-cytokine activity properties.
The SEC noted that Zuventus had presented revised Phase 3 clinical trial protocol before the committee, and after “detailed deliberation”, it recommended grant of permission of Phase 3 trials with the drug, “subject to condition that criteria for discharge of patients from intensive care unit should be defined clearly in the protocol”.
As for DRL, the SEC has noted that the trial should be termed Phase 3 clinical trial instead of Phase 2/3 trial.
I don't think that RLFTF would be positioning itself for a Nasdaq uplisting unless they were confident that trial results are going to be good. There would be no point to uplist with bad trial results. How quickly could a Nasdaq uplisting happen?
I wonder how many deaths there will be? During the interim analysis, Nader's slide said ~45 which is weird because he knew EXACTLY how many deaths there were. So why the ~ symbol? During his presentation he mumbled something about 50 deaths. This is typical Nader. And when he said 87 deaths before the trial completed, we don't know if this is true. Nader always twists and manipulates the truth. The 87 deaths might have been true a few weeks earlier and Nader might have "forgotten" to include a few of the most recent deaths. Nader knows that 90+ deaths would make it obvious that the trial failed. Given the choice to be honest about the trial failing, Nader will lie EVERY time.
There is only 1 Samantha Mottet in the US. She was born in Tell City, IN. She lived most of her adult life in Lake Oswego, OR. She currently lives in Seal Beach, CA with her lucky to be alive husband Harold. Due diligence is not difficult
Why is no one talking about the Proactive Investors article? Proactive Investors only writes articles that they are paid to do. At a time when we are expecting the topline data to be released, Proactive writes an article downplaying leronlimab's Covid S/C indication and highlighting leronlimbab's other indications. This article is clearly an attempt at a pivot. Nader wants you to be thinking about the other indications when they release the poor topline data. https://www.proactiveinvestors.com/companies/news/902994/cytodyn-has-multiple-shots-on-goal-with-its-flagship-drug-vyrologix-to-treat-for-hiv-various-cancers-and-even-coronavirus-902994.html